Debra Yu
2021
In 2021, Debra Yu earned a total compensation of $9.7M as President & Chief Strategy Officer at LianBio, a 186% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $634,375 |
|---|---|
| Option Awards | $8,350,967 |
| Salary | $500,000 |
| Stock Awards | $105,324 |
| Other | $88,542 |
| Total | $9,679,208 |
Yu received $8.4M in option awards, accounting for 86% of the total pay in 2021.
Yu also received $634.4K in non-equity incentive plan, $500K in salary, $105.3K in stock awards and $88.5K in other compensation.
Rankings
In 2021, Debra Yu's compensation ranked 1,094th out of 12,415 executives tracked by ExecPay. In other words, Yu earned more than 91.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,094 out of 12,415 | 91st |
Division Manufacturing | 374 out of 5,505 | 93rd |
Major group Chemicals And Allied Products | 135 out of 2,375 | 94th |
Industry group Drugs | 114 out of 2,096 | 95th |
Industry Pharmaceutical Preparations | 77 out of 1,546 | 95th |
Source: SEC filing on April 27, 2022.
Yu's colleagues
We found three more compensation records of executives who worked with Debra Yu at LianBio in 2021.